Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism 2023-01-06 18:00
SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock 2023-01-06 09:10
WAYCEN, the first medical AI company to win 4 CES 2023 innovation awards "Proved K-Medtech" 2023-01-06 00:00
Global Times: China shifts COVID policy with necessary conditions 2023-01-05 23:21
Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report 2023-01-05 22:00
Yunji Successfully Concludes its New Year Festive Goods Shopping Festival 2023-01-05 19:00
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement 2023-01-05 18:30
B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo 2023-01-05 15:00
Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 09:00
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo 2023-01-05 09:00
Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference 2023-01-05 00:00
Lunit to Supply AI Solution for Chest X-Ray Analysis to Albert Einstein, Latin America's Largest Hospital 2023-01-04 21:20
Waterdrop and Jemincare Collaborate on the "Digital Service Platform for CKD Patients" 2023-01-04 21:00
OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors 2023-01-04 21:00
Sihuan Pharmaceutical（0460.HK）: Huisheng Biopharmaceutical Successfully Completed the A + Round of Financing 2023-01-04 15:52
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum 2023-01-03 23:25
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test 2023-01-03 22:24
Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023 2023-01-03 22:00
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC 2023-01-03 20:00
Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-03 14:10
1 120 121 122 123 124 812